SA国际传媒

SA国际传媒
Sponsored Content

Avive Solutions Receives FDA Approval of Handheld Automated External Defibrillator (AED) with Unique Capabilities

Sponsored by

Groundbreaking Avive Connect AED鈩 combines cellular and WiFi connectivity, GPS technology, remote maintenance and extreme portability in handheld device.

SAN FRANCISCO , has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA)- the agency鈥檚 highest level of approval鈥 for its Avive AED鈩, a unique Automated External Defibrillator (AED).

Customers can pre-order the product now and learn more at . The waitlist currently includes police and fire departments, higher education institutions, cities and counties, nationwide gym chains, small businesses, families and individuals. New orders are expected to begin shipping this summer.

For decades, AEDs have been used to treat victims of Sudden Cardiac Arrest, one of the leading causes of death outside the hospital globally. With , out-of-hospital cardiac arrest (OHCA) leads to more than 350,000 deaths annually.

鈥淓very minute a person in cardiac arrest does not receive a shock from an AED, their chance of survival drops seven to ten percent,鈥 said Sameer Jafri, Avive co-founder and CEO. 鈥淲ithout rapid intervention with an AED and Hands-Only CPR before EMS arrival, their chance of survival is dramatically reduced. To improve those odds, our focus these past five years has been creating and validating a small, fully connected device that鈥檚 easy to access and use. It鈥檚 called the Avive Connect AED.鈥

This 2.1 pound device is the only market-ready product with Cellular, WiFi, GPS, and Bluetooth connectivity. This connectivity suite powers Avive鈥檚 revolutionary REALConnect鈩 Technology. It鈥檚 designed to help get life-saving therapy to a person when and where it鈥檚 needed by integrating with 911 centers through a partnership with RapidSOS. It also seamlessly transfers valuable incident data to 911 telecommunicators, EMS, and medical professionals at the right time. REALConnect鈩 can also automate remote monitoring of Avive鈥檚 AEDs to ensure they are properly maintained and fully functional.

avive connect aed was designed to improve survival rates

It鈥檚 estimated more than four million AEDs have been deployed around the U.S in an effort to provide quick, lifesaving intervention for OHCA events. However, timely response before EMS arrival and actual use of those deployed AEDs remains below three percent . The result is survival rates nationwide have remained unchanged for years at about ten percent.

To improve survival rates, the Avive Connect AED was designed for easy placement in a variety of locations, optimized for maximum connectivity, and extensively tested for
ease-of-use.

鈥淭he opportunity to dramatically transform cardiac arrest response and improve outcomes is now possible in ways that weren鈥檛 imagined even a few years ago,鈥 said Rory Beyer, Avive co-founder & President. 鈥淭he power of our platform is its ability to connect the different elements of a cardiac arrest response. More connections mean more valuable data can get to the right people at the right time. This approach mirrors the paradigm shifts and benefits we have seen connected devices bring to other industries such as smartphones, home security, personal fitness, automobiles and more.鈥

The University of Pennsylvania鈥檚 Director of the Center of Resuscitation Science, Benjamin Abella, M.D., is a global thought leader in sudden cardiac arrest research who has published more than 250 papers on cardiac arrest and resuscitation. Like a growing number of physician and public safety leaders, he supports the potential of this interconnected, data-driven, 鈥渞ight place, right time鈥 approach for improving outcomes.

鈥淐onnected devices are the future of emergency care. Decades of experience tell me that Avive鈥檚 technology and approach will be game changing,鈥 said Dr. Abella. 鈥淎EDs have historically been like fire extinguishers. You put one on the wall and forget about it. But when flames erupt, you need it to work, and you need to know where to find it.鈥

鈥淲hen a cardiac event occurs down the street, where鈥檚 the fire extinguisher for that, so to speak? Experience says it could be what Avive has created. A powerful, portable device that鈥檚 interconnected into the public safety and provider ecosystem opens up the possibilities for AEDs to get used more often and more effectively. Also, valuable data from an AED can finally be seamlessly sent to emergency departments to support downstream patient care decisions. That鈥檚 rare today.鈥

avive eliminates manual, burdensome, costly maintenance

AED maintenance is critical to ensure functionality. While some AEDs have limited wireless capabilities, most have none. This requires AED owners to perform manual inspections of their devices, a burdensome, costly and often unreliable process.

With a full suite of connectivity, Avive simplifies AED monitoring and maintenance for its customers through daily remote monitoring of their fleet of devices using Avive鈥檚 REALConnect Platform.鈩 鈥 which customers can easily access from their laptop or mobile phone.

鈥淲e鈥檙e giving our customers unprecedented insight into their Avive Connect AEDs,鈥 said Jafri. 鈥淥ur REALConnect Platform makes it easy to deploy and manage their devices, whether it鈥檚 a handful of them or thousands. Customers will now have the tools and information to make sure their AEDs are properly maintained and are where they expect them to be.鈥

About Avive Solutions, Inc.

is a San Francisco-based healthcare technology company and developer and manufacturer of a revolutionary connected Automated External Defibrillator (AED), coupled with a first-of-its-kind software platform to address the major healthcare problem of out-of-hospital cardiac arrest (OHCA). Avive鈥檚 connected hardware and software platform is designed to integrate with existing public safety and provider ecosystems to create a comprehensive OHCA response solution. The goal is increased survival rates from cardiac arrest emergencies. Stay up to date by subscribing to our , and following us on , , and , and .